History

L. Joseph Wheat, M.D. founded MiraVista Diagnostics and MiraBella Technologies in 2002. Both organizations focus on developing improved fungal diagnostic testing. For over two decades, Dr. Wheat served as a Professor of Medicine and Pathology at Indiana University School of Medicine, Indianapolis, where his research yielded the Histoplasma antigen test. With MiraVista Diagnostics and MiraBella Technologies, Dr. Wheat continues to focus on the development of high-complexity tests coupled with same-day referral testing.

Vision

Our vision is to produce new tests in compliance with cGMP quality standards and to attain FDA clearance to distribute these tests to reference laboratories. To realize this vision, we have assembled highly specialized personnel, established a technology-driven environment, and made the commitment to seek FDA clearance of products that are appropriate for incorporation into large referral laboratory testing. At the same time, we continue to provide high quality, same-day testing services at MiraVista Diagnostics.

Description

MiraVista Diagnostics. MiraVista Diagnostics was formed to provide Histoplasma antigen testing to customers throughout the United States. Since the company’s inception, additional tests have been incorporated into our menu of services. New rapid tests developed by MiraBella Technologies or selected tests available commercially will be added to our referral services. MiraVista also serves as the US agent for Statens Serum Institut (Copenhagen, DK), handling sales and distribution of their products in the US.